A breakthrough on cancer therapy by inhibition of negative immune regulation: nobel prize in physiology or medicine 2018
Resumen
James P. Allison from the MD Anderson Cancer Center, University of Texas, and Tasuku Honjo from Kyoto university were jointly awarded the prestigious Nobel Prize in Physiology/Medicine 2018. Their therapeutic research is on the inhibition of CTLA-4 and PD-1, two proteins which act as a blockade and prevent the immune system from attacking tumor cells.
Fuente
National Academy Science Letters, 43(7), 681-685Link de Acceso
Click aquí para ver el documentoIdentificador DOI
doi.org/10.1007/s40009-020-00940-0Colecciones
La publicación tiene asociados los siguientes ficheros de licencia:
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile